Literature DB >> 24495923

China should reduce the overuse of intravenous infusion.

Sanying Yuan.   

Abstract

Mesh:

Year:  2014        PMID: 24495923     DOI: 10.1136/bmj.g1262

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Overuse of intravenous infusions in China: focusing on management platform and cultural problems.

Authors:  Shuangshuang Zeng; Dong Wang; Wanli Liu; Yuanliang Yan; Minwen Zhu; Zhicheng Gong; Shusen Sun
Journal:  Int J Clin Pharm       Date:  2019-08-30

2.  Out-of-Pocket Household Expenditures on Medical Injections in Cambodia.

Authors:  Sachiko Ozawa; Tatenda T Yemeke; Alie F Tawah; Vivek Kulkarni; Manuela Villar Uribe
Journal:  Pharmacoecon Open       Date:  2018-12

3.  Probing popular and political discourse on antimicrobial resistance in China.

Authors:  An Yi Yu; Susan Rogers Van Katwyk; Steven J Hoffman
Journal:  Glob Health Res Policy       Date:  2019-02-28

4.  Medication Use During Pregnancy in Mainland China: A Cross-Sectional Analysis of a National Health Insurance Database.

Authors:  Jingyuan Zhang; Carolina Oi Lam Ung; Anita Katharina Wagner; Xiaodong Guan; Luwen Shi
Journal:  Clin Epidemiol       Date:  2019-12-10       Impact factor: 4.790

5.  The influence of a ban on outpatient intravenous antibiotic therapy among the secondary and tertiary hospitals in China.

Authors:  Xiaomin Wang; Dan Wu; Ziming Xuan; Weiyi Wang; Xudong Zhou
Journal:  BMC Public Health       Date:  2020-11-25       Impact factor: 3.295

6.  Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study.

Authors:  Jing Zhang; Jinping Zheng; Kewu Huang; Yahong Chen; Jingping Yang; Wanzhen Yao
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.